Staab, Thomas R.; Walter, Miriam; Mariotti Nesurini, Sonja; Dintsios, Charalabos-Markos; Schulenburg, Johann-Matthias Graf von der; Amelung, Volker E.; Ruof, Jörg
(London : BioMed Central Ltd., 2018)
Background: According to the AMNOG act, the German Federal Joint Committee (G-BA) determines the additional benefit of new medicines as a basis for subsequent price negotiations. Pharmaceutical companies may withdraw their ...